Targeting Bruton’s tyrosine kinase in vitreoretinal lymphoma: an open-label, prospective, single-center, phase 2 study

Vitreoretinal lymphoma (VRL) is strongly linked to central nervous system (CNS) progression with no standard treatment approaches. Commonly used strategies include repeated intraocular injections of low-dose methotrexate or local radiotherapy, with great inconvenience, long-term side effects, and hi...

Descripción completa

Detalles Bibliográficos
Autores principales: Guan, Wenxue, Wang, Liang, Peng, Xiaoyan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Correspondence
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9644621/
https://www.ncbi.nlm.nih.gov/pubmed/36348442
http://dx.doi.org/10.1186/s40164-022-00354-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9644621/
https://www.ncbi.nlm.nih.gov/pubmed/36348442
http://dx.doi.org/10.1186/s40164-022-00354-2

Ejemplares similares